Position in ELAN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$737,618
+$719,150 QoQ
Shares Held
30,824
+3261.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Wealthspire Advisors, LLC holds $1,941,772 across 6 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (38.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
7,687 | $908,680 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
30,824 | $737,618 | |
| 3 | AKBA |
Akebia Therapeutics, Inc.
|
180,002 | $250,202 | |
| 4 | OGI |
Organigram Global Inc.
|
18,522 | $24,819 | |
| 5 | CRDL |
Cardiol Therapeutics Inc.
|
15,151 | $20,453 | |
| 6 | RMTI |
Rockwell Medical, Inc.
|
151,838 | $0 |
All Filings in ELAN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $737,618 | 30,824 | Shares | Sole | 2026-05-01 | |
| 2025-09-30 | $18,468 | 917 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||